Cost-effectiveness of Anbainuo plus methotrexate compared to conventional disease-modifying antirheumatic drugs for rheumatoid arthritis patients in China

BACKGROUND: This study aimed to evaluate the cost-effectiveness of Anbainuo (ABN) plus methotrexate (MTX) vs. conventional disease-modifying antirheumatic drugs (cDMARDs) in Chinese rheumatoid arthritis (RA) patients. METHODS: A total of 90 RA patients who underwent ABN + MTX [assigned as ABN + MTX...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Feng, Wen, Zhenhua, Li, Jingyang, Luo, Xiaowen, Deng, Li, Zhang, Liang, He, Jingyun, Yao, Fangling, Liao, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350709/
https://www.ncbi.nlm.nih.gov/pubmed/34430606
http://dx.doi.org/10.21037/atm-21-3132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350709/
https://www.ncbi.nlm.nih.gov/pubmed/34430606
http://dx.doi.org/10.21037/atm-21-3132

Ejemplares similares